In the early stages of the process, there wasn't much certainty, and the agency made decisions quickly. As I said, the fact that it purchased an additional 370,000 doses even though it knew that the first 500,000 doses purchased weren't being used much is hard to explain. However, it's not up to us to explain it; that's the agency's job. Maybe they'll come here to do it.
As I said before, how can we learn from this situation to better prevent and avoid waste in the future? That's at the heart of our recommendation.